METHODS FOR TREATING AGE-RELATED MACULAR DEGENERATION
US20260098085A1 · Application publication visible
immortal.lifeExplore source-linked longevity patent families and topic connections associated with the applicant name Novartis AG.
This independent page groups EPO bibliographic records in which this name appears as an applicant or assignee. It is not a corporate profile, ownership opinion, portfolio valuation or ranking.
US20260098085A1 · Application publication visible
NZ761026A · Application publication visible